Symposium introduction: metabolic syndrome and the onset of cancer - PubMed (original) (raw)

Symposium introduction: metabolic syndrome and the onset of cancer

Jin-Rong Zhou et al. Am J Clin Nutr. 2007 Sep.

Abstract

Diabetes, obesity, and related metabolic disorders are among the most pressing of today's health care concerns. Recent evidence from epidemiologic and basic research studies, as well as translational, clinical, and intervention studies, supports the emerging hypothesis that metabolic syndrome may be an important etiologic factor for the onset of cancer. On March 15-16, 2006, The Harvard Medical School Division of Nutrition hosted the symposium "Metabolic Syndrome and the Onset of Cancer" as a platform to systematically evaluate the evidence in support of this hypothesis. This symposium, which gathered leaders in the fields of metabolism, nutrition, and cancer, will stimulate further research investigating the etiologic role of metabolic syndrome in cancer. Furthermore, it will help to guide the development of effective cancer prevention strategies via nutritional and lifestyle modifications to alleviate metabolic syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors had no conflicts of interest to disclose.

Similar articles

• Obesity modulation - the role in carcinogenesis.
  Legakis I, Syrigos K. Legakis I, et al. Anticancer Agents Med Chem. 2010 Jul;10(6):481-90. doi: 10.2174/1871520611009060481. Anticancer Agents Med Chem. 2010. PMID: 20698826 Review.
• Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer.
  Gallagher EJ, LeRoith D. Gallagher EJ, et al. Diabetes Care. 2013 Aug;36 Suppl 2(Suppl 2):S233-9. doi: 10.2337/dcS13-2001. Diabetes Care. 2013. PMID: 23882051 Free PMC article. Review. No abstract available.
• [Alimentary and lifestyle changes as a strategy in the prevention of metabolic syndrome and diabetes mellitus type 2: milestones and perspectives].
  M Hernández Ruiz de Eguilaz M, Batlle MA, Martínez de Morentin B, San-Cristóbal R, Pérez-Díez S, Navas-Carretero S, Martínez JA. M Hernández Ruiz de Eguilaz M, et al. An Sist Sanit Navar. 2016 Mayo-Agosto;39(2):269-89. doi: 10.23938/ASSN.0267. An Sist Sanit Navar. 2016. PMID: 27599954 Review. Spanish.
• Metabolic syndrome and risk of cancer: a systematic review and meta-analysis.
  Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D. Esposito K, et al. Diabetes Care. 2012 Nov;35(11):2402-11. doi: 10.2337/dc12-0336. Diabetes Care. 2012. PMID: 23093685 Free PMC article. Review.
• Metabolic syndrome and cancer-related mortality among Korean men and women.
  Lee JS, Cho SI, Park HS. Lee JS, et al. Ann Oncol. 2010 Mar;21(3):640-645. doi: 10.1093/annonc/mdp344. Epub 2009 Sep 16. Ann Oncol. 2010. PMID: 19759188

Cited by

• The impact of the microbiome in cancer: Targeting metabolism of cancer cells and host.
  Huang JT, Mao YQ. Huang JT, et al. Front Oncol. 2022 Nov 16;12:1029033. doi: 10.3389/fonc.2022.1029033. eCollection 2022. Front Oncol. 2022. PMID: 36465375 Free PMC article. Review.
• The combination of metabolic syndrome and inflammation increased the risk of colorectal cancer.
  Liu T, Fan Y, Zhang Q, Wang Y, Yao N, Song M, Zhang Q, Cao L, Song C, Shi H. Liu T, et al. Inflamm Res. 2022 Aug;71(7-8):899-909. doi: 10.1007/s00011-022-01597-9. Epub 2022 Jun 18. Inflamm Res. 2022. PMID: 35715516 Free PMC article.
• The Importance of Metabolic Syndrome Status for the Risk of Non-Viral Hepatocellular Carcinoma: A Nationwide Population-Based Study.
  Cho Y, Cho EJ, Yoo JJ, Chang Y, Chung GE, Choi IY, Park SH, Han K, Kim YJ, Yoon JH, Shin DW, Yu SJ. Cho Y, et al. Front Oncol. 2022 May 4;12:863352. doi: 10.3389/fonc.2022.863352. eCollection 2022. Front Oncol. 2022. PMID: 35600376 Free PMC article.
• Protective and therapeutic role of mango pulp and eprosartan drug and their anti-synergistic effects against thioacetamide-induced hepatotoxicity in male rats.
  Shaban NZ, Zaki MM, Koutb F, Abdul-Aziz AA, Elshehawy AA, Mehany H. Shaban NZ, et al. Environ Sci Pollut Res Int. 2022 Jul;29(34):51427-51441. doi: 10.1007/s11356-022-19383-9. Epub 2022 Mar 4. Environ Sci Pollut Res Int. 2022. PMID: 35244847 Free PMC article.

References

1. 1. Reaven GM Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–1607. - PubMed
2. 1. Stoll BA. Western nutrition and the insulin resistance syndrome: a link to breast cancer. Eur J Clin Nutr. 1999;53:83–87. - PubMed
3. 1. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579–591. - PubMed
4. 1. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005;293:194–202. - PubMed
5. 1. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med. 2006;166:1871–1877. - PubMed

Publication types

MeSH terms

Grants and funding

• P30 DK040561/DK/NIDDK NIH HHS/United States
• P30 DK046200/DK/NIDDK NIH HHS/United States
• P30-DK-46200/DK/NIDDK NIH HHS/United States
• R03 CA130133/CA/NCI NIH HHS/United States
• P30 DK040561-12/DK/NIDDK NIH HHS/United States
• R01 CA092546/CA/NCI NIH HHS/United States
• R03 CA130131/CA/NCI NIH HHS/United States
• P30-DK-40561/DK/NIDDK NIH HHS/United States

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Europe PubMed Central
  • PubMed Central
  • Silverchair Information Systems

• Medical

  • MedlinePlus Health Information